Rani Therapeutics Holdings annual revenue
2020
2021
2022
2023
2024
2025
Rani Therapeutics Holdings Revenue Growth & History (RANI)
Rani Therapeutics Holdings reported $1.6M in revenue for fiscal 2025, an increase of 58.85% from the previous fiscal year.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.6M | $605,000 | +58.85% |
| 2024 | 2024-12-31 | $1.0M | $1.0M | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$2.7M | −100.00% |
| 2021 | 2021-12-31 | $2.7M | $2.3M | +488.10% |
| 2020 | 2020-12-31 | $462,000 | — | — |
Rani Therapeutics Holdings quarterly revenue
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q2.22
Q3.22
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.7M | $1.7M | — |
| Q1 2026 | 2026-03-31 | $1.7M | $1.5M | +893.02% |
| Q4 2025 | 2025-12-31 | $1.5M | $433,000 | +42.12% |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $172,000 | $172,000 | — |
| Q4 2024 | 2024-12-31 | $1.0M | — | — |
| Q3 2024 | 2024-09-30 | $0 | — | — |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | −$2.0M | −100.00% |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | −$108,000 | −100.00% |
| Q2 2021 | 2021-06-30 | $2.0M | $1.9M | +3168.33% |
| Q1 2021 | 2021-03-31 | $756,000 | — | — |
| Q3 2020 | 2020-09-30 | $108,000 | — | — |
| Q2 2020 | 2020-06-30 | $60,000 | — | — |
Rani Therapeutics Holdings revenue growth trends
Over the last five reported fiscal years, revenue grew from $462,000 to $1.6M, a compound annual growth rate of 28.73%. Rani Therapeutics Holdings's latest reported quarter, Q2 2026, generated $1.7M in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Rani Therapeutics Holdings source filings ↗